Healthcare worker experiences with Option B+ for prevention of mother-to-child HIV transmission in eSwatini: findings from a two-year follow-up study

Giphart A(2017)HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town South Africa HIV Med 18 80-1012

Guay LA(2009)Challenges for routine health system data management in a large public programme to prevent mother-to-child HIV transmission in South Africa PLoS One 4 1-601

Musoke P(2015)Challenges with routine data sources for PMTCT programme monitoring in East Africa: insights from Tanzania Glob Health Action 8 1-156

Fleming T(2015)Implementation and operational research: effects of antenatal care and HIV treatment integration on elements of the PMTCT Cascade: results from the SHAIP cluster-randomized controlled trial in Kenya J Acquir Immune Defic Syndr 69 e172-undefined

Adler RM(2010)Comparing two service delivery models for the prevention of mother-to-child transmission (PMTCT) of HIV during transition from single-dose nevirapine to multi-drug antiretroviral regimens BMC Public Health 10 753-undefined

Riley P(2016)Lessons learned from the PMTCT program in Swaziland: challenges with accepting lifelong ART for pregnant and lactating women -- a qualitative study BMC Public Health 16 1119-undefined

Bandazi S(2012)Women’s views on consent, counseling and confidentiality in PMTCT: a mixed-methods study in four African countries BMC Public Health 12 26-undefined

Davis KM(2016)Adherence to antiretroviral therapy during and after pregnancy: cohort study on women receiving Care in Malawi’s “option B+” Programme Clin Infect Dis 63 1227-undefined

Schuster RC(2016)Retention in care of HIV-infected pregnant and lactating women starting ART under option B+ in rural Mozambique Trop Med Int Heal 21 1003-undefined

McMahon DE(2014)Option B+ for prevention of mother-to-child transmission of HIV in resource-constrained settings Aids. 28 599-undefined

Giphart A(2017)HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town South Africa HIV Med 18 80-1012

Guay LA(2009)Challenges for routine health system data management in a large public programme to prevent mother-to-child HIV transmission in South Africa PLoS One 4 1-601

Musoke P(2015)Challenges with routine data sources for PMTCT programme monitoring in East Africa: insights from Tanzania Glob Health Action 8 1-156

Fleming T(2015)Implementation and operational research: effects of antenatal care and HIV treatment integration on elements of the PMTCT Cascade: results from the SHAIP cluster-randomized controlled trial in Kenya J Acquir Immune Defic Syndr 69 e172-undefined

Adler RM(2010)Comparing two service delivery models for the prevention of mother-to-child transmission (PMTCT) of HIV during transition from single-dose nevirapine to multi-drug antiretroviral regimens BMC Public Health 10 753-undefined

Riley P(2016)Lessons learned from the PMTCT program in Swaziland: challenges with accepting lifelong ART for pregnant and lactating women -- a qualitative study BMC Public Health 16 1119-undefined

Bandazi S(2012)Women’s views on consent, counseling and confidentiality in PMTCT: a mixed-methods study in four African countries BMC Public Health 12 26-undefined

Davis KM(2016)Adherence to antiretroviral therapy during and after pregnancy: cohort study on women receiving Care in Malawi’s “option B+” Programme Clin Infect Dis 63 1227-undefined

Schuster RC(2016)Retention in care of HIV-infected pregnant and lactating women starting ART under option B+ in rural Mozambique Trop Med Int Heal 21 1003-undefined

McMahon DE(2014)Option B+ for prevention of mother-to-child transmission of HIV in resource-constrained settings Aids. 28 599-undefined